7__Strategic Partnering Financing Process (2).pptx

8/9/2019 7__Strategic Partnering Financing Process (2).pptx

1/31

Diabetic Nephropathy

Diabetic Retinopathy

Hypercholesterolemia

Oral Mucositis

Gout

Acute Lymphocytic Leukemia

Bone Metastasis

Brain Cancer

Breast Cancer

Cervical Cancer

Chronic Lymphocytic Leukemia

Enometrial Cancer

E!in" #arcoma

Gastric Cancer

Gastrointestinal #tromal $umors

Hea An Neck CancerHo"kin Lymphoma

%iney Cancer

Liver Cancer

Mali"nant Mesothelioma

Meullary $hyroi Cancer

Melanoma

Multiple Myeloma

Non&Ho"kin Lymphoma

Nonmall Cell Lun" Cancer

Ovarian Cancer

'ancreatic Cancer

$esticular Cancer

$hyroi Cancer

A"e Relate Macular De"eneration

%eratocon(unctivitis sicca )Dry Eye*

Retinal +ein Occlusion

Acute Respiratory Distress#ynrome

#epsis

#taphylococcal ,n-ections

Acute Coronary #ynrome

An"ina 'ectoris

Atrial .ibrillation

Coronary Artery Disease )CAD*

Critical Limb ,schemia

Hypertension

'ulmonary Arterial Hypertension

Acute 'ain

An/iety Disorers

Chronic 'ain

Dementia

Diabetic Neuropathy

Obsessive&Compulsive DisorerOsteoarthritis 'ain

'arkinson0s Disease

'ost&$raumatic #tress Disorer

Restless Le"s #ynrome

#chi1ophrenia

$raumatic Brain ,n(ury

Liver Cirrhosis

Chilhoo Enuresis

Gro!th Hormone Disorers

Hyperparathyroiism

Hyperthyroiism

Guillain&Barre #ynrome

Cytome"alovirus

.un"al ,n-ections

Gram&Ne"ative Bacterial ,n-ections

H2N2 ,n-ectionHerpes 3oster

H,+&2 ,n-ection

Human 'apillomavirus ,n-ections

#taphylococcus Aureus )MR#A*

Cariovascular Devices

'rosthetic Heart +alve

'eripheral +ascular Devices

Cariovascular Monitorin" 4 Dia"nostic Devices

Cariovascular #ur"ery

Cariac Rhythm Mana"ement

Cariovascular 'rosthetic Devices

,nterventional Cariolo"y

Cariac Assist Devices

5oun Care Mana"ement

Hospital #upplies

#yrin"es an Neeles

Disposable Hospital 4 #ur"ical #upplies

Dru" Delivery Devices

,nhalation #ystems

Neele .ree ,n(ections,n-usion #ystems

Diabetes Care Devices

,nsulin Delivery 4 Glucose Monitorin"

Ophthalmic Devices

Cataract #ur"ery Devices

Ophthalmic Dia"nostic E6uipment

Re-ractive #ur"ery Devices

EN$ Devices

Hearin" ,mplants

Dia"nostic Devices

Electrosur"ical Devices

Dental E6uipment 4 Accessories

Dia"nostic ,ma"in" 4 MR, #ystems

C7$ #ystems 4 Mammo"raphy E6uipment

8&Ray 4 9ltrasoun #ystems

Nuclear ,ma"in" E6uipmentContrast Meia ,n(ectors

Bone Densitometry

Anesthesia an Respiratory Devices

Anesthesia Machines 4 Disposables

Respiratory Devices 4 Disposables

#leep Apnea Dia"nostic #ystems

Healthcare ,$

Meical ,ma"in" ,n-ormation #ystems

Nephrolo"y an 9rolo"y Devices

Renal Dialysis E6uipment

Orthopeic Devices

Orthobiolo"ics 4 Arthroscopy

:oint Reconstruction

$rauma .i/ation

Orthopeic 'rosthetics

Cranium Ma/illo-acial .i/ation )CM.*

#pinal #ur"ery

Enoscopy Devices 4 instruments

Ri"i 4 .le/ible Enoscope

,n +itro Dia"nostics

Genetic $estin"

Clinical Chemistry

Hematolo"y

,mmuno Chemistry

,n-ectious ,mmunolo"y

Histolo"y An Cytolo"y

'atient Monitorin"

Multiparameter 'atient Monitorin"

Micro&Electromechanical #ystems

Non&invasive Bloo 'ressure Monitors

Neurolo"y Devices

Neurostimulation Devices

,nterventional Neurolo"yC#. Mana"ement

Neurosur"ical 'roucts

Raiosur"ery

M

EDTE

CH

&

DIA

GNOSTIC

S

BIOPH

ARM

ACE

UTICALS

Healthios

Capital Formatio

Pro!ess


2/31

Research. Investment Banking. Healthcare.

Ta"le o# Cotets

I. Executive Summary

Appe$i!es

II% StaeONE:

Optimizing the Companys position BEFORE, DURING &AFTER the Transation

II% Stae '(!"anning the Transation

III% Stae )( Con#irming Interest

I*% Stae +( Capita" $ar%ets

*% Stae ,( De Di"igene

*I% Stae -( Negotiation & C"ose


3/31




Oral Mucositis

Gout


Bone Metastasis

Brain Cancer

Breast Cancer

Cervical Cancer


Enometrial Cancer

E!in" #arcoma

Gastric Cancer


Hea An Neck CancerHo"kin Lymphoma

%iney Cancer

Liver Cancer



Melanoma

Multiple Myeloma

Non&Ho"kin Lymphoma


Ovarian Cancer

'ancreatic Cancer

$esticular Cancer

$hyroi Cancer





#epsis



An"ina 'ectoris

Atrial .ibrillation



Hypertension


Acute 'ain

An/iety Disorers

Chronic 'ain

Dementia

Diabetic Neuropathy


'arkinson0s Disease



#chi1ophrenia


Liver Cirrhosis

Chilhoo Enuresis


Hyperparathyroiism

Hyperthyroiism


Cytome"alovirus

.un"al ,n-ections


H2N2 ,n-ectionHerpes 3oster

H,+&2 ,n-ection













Hospital #upplies

#yrin"es an Neeles



,nhalation #ystems




Ophthalmic Devices




EN$ Devices

Hearin" ,mplants

Dia"nostic Devices







Bone Densitometry





Healthcare ,$




Orthopeic Devices



$rauma .i/ation



#pinal #ur"ery

Enoscopy Devices 4 instruments



Genetic $estin"

Clinical Chemistry

Hematolo"y

,mmuno Chemistry



'atient Monitorin"




Neurolo"y Devices




Raiosur"ery

M

EDTE

CH

&

DIA

GNOSTIC

S

BIOPH

ARM

ACE

UTICALS

E.e!/ti0e S/mmar1


4/31

Healthcares Investment Bank

Stratei! Alterati0es & Fia!i Pro!ess'ea"thios transation proess has (een per#ete) e*"si+e"y #or the emerging groth hea"thare

ommnity, integrating proprietary tehni-es an) e*"si+e resores to optimize ertainty,

e##iieny an) aess #or the transation hi"e ma*imizing otomes #or the Company.

STAGE '(

Plai

the Trasa!tio

Xchange Profile

Document

Development

Financial Model

to Pea! "alue

#lternative$

%evie&

Match' (arget )

*eo+ocate

,ommitment

,ommittee

Deal

La/!h

,ommercial'

Strategy D.D.

(echnical

Evaluation

Financial Model

-rganiational

Matter$

Financing

,on$ideration$

-perating Plan

De#iiti0e

Areemet

STAGE ,(

D/e

Dilie!e

Finalie (erm$ )

Structure

File %egulatory

#pproval$' if any

Finalie

Integration Plan

Final

Documentation

/oard #pproval$

Close

STAGE -(

Neotiatios &

Close

,onfirming the

%ule Set!.

(each0In &ith

Direct Inve$tor$

Management

1e2,a$t

%oad$ho& &3

Mgmt.. ) +ead

E$ta2li$h SP" 3

Side ,ar!

Syndication )

#llocation$

Dire!t

I0estmet

STAGE +(

Capital

Mar2ets

Engagement

Po$itioning )

,ommunication

Solicitation )

Follo& 4p

Management

Meeting$

Data %oom

(rending Data'

#ctivity' Scoring

Lea$ 3

L%O%I%

STAGE )(

Co#irmi

Iterest

STAGE

ONE


5/31


Stae ONE( Be#ore4 D/ri4 A#ter the Deal'ea"thios/hange ena("es Emerging Groth hea"thare ompanies to optimize their most

important #inaning an) strategi priorities throghot the entire in+estment horizon

Selection )Segmentation

#$$em2lingEcoSy$tem$

,ompany+i$ting$

Pre$entation$ )-3M

5-+ 3Maret Data

Management )/-D

Compa1

Pro#ile

Friend$ )

Follo&er$

,ommunitie$ )

*roup$

,linical )

Maret %e$earch(agging

Xchange

+ife+ine$!

Integrated Social

Media

E!oS1stem

Positioi

,u$tom ,ontent6e&$ Flo&

6otification$

Private 3 Pu2lic

"aluation$

Xchange +ive!

7o$ted ,hat

%ating$ )

%evie&$

Expert -pinion

1e2,a$t$Eaemet

(argeting )(racing

Me$$aging )#lert$

*rand %ound$!1e2,a$t

Shar (an!Xchange

,onference$Relatioship

89 million Data

Point$

';;; ,oncurrent

Experiment$

(rending )

#ctivity Score$

Mile$tone$ )

Inflection Point$

Sentiment )

Prediction

Meas/res &

S!ori


6/31


Proprietar1 Capital Mar2ets O##eris'ea"thios o##ers a range o# apita" mar%ets so"tions to spport the #inaning an)

strategi nee)s o# Emerging Groth hea"thare ompanies.

Deal

La/!h

De#iiti0e

AreemetClose

Dire!t

I0estmet

Lea$ 3

L%O%I%

STAGE '(Plai

the Trasa!tio

STAGE ,(D/e

Dilie!e

STAGE -(Neotiatios &

Close

STAGE +(Capital

Mar2ets

STAGE )(Deal

De0elopmet

STAGE

ONE

MANAGED MAR5ET OFFERING 6!hae S7NDICATED OFFERING

,omprehen$ive corporate financing $olution (argeted tran$action $olution

Managed 2y $enior inve$tment 2aning team Parallel to ,ompany0led deal effort$

,omplete document management ) financialmodeling

4$e exi$ting documentation ) financial$

4nlimited +ead! inve$tor target$ active inve$tor target$ at all time$

Integrated mareting' $olicitation ) follo&0up 4$er0managed' Xchange0lined mareting

Dedicated capital maret$ ) in$titutional $ale$

team

4pon $ecuring +ead! inve$tor$: De)iate) apita" mar%ets spport

Diret in+estment syn)iation

Parallel direct inve$tment $yndication %eal0time electronic update$

1eely management ) /oard report$


7/31Healthcares Investment Bank

6!hae(MS1$i!ate$ O##eriThe/hange

T$

0yn)iate) O##ering is a e*"si+e apita" mar%ets ser+ie hih a""os Emerging

Groth Companies to manage their on transations, emp"oying the proprietary apa(i"ities o# the

'ea"thios/hange to prse optima" res"ts in a or")1"ass )ea" en+ironment.

,ommercial'

Strategy D.D.

(echnical

Evaluation

Financial Model

-rganiational

Matter$

Financing

,on$ideration$

-perating Plan

De#iiti0e

Areemet

STAGE ,(

D/e

Dilie!e

Finalie (erm$ )

Structure

File %egulatory

#pproval$' if any

Finalie

Integration Plan

Final

Documentation

/oard #pproval$

Close

STAGE -(

Neotiatios &

Close

,onfirming the

%ule Set!.

(each0In &ith

Direct Inve$tor$

Management

1e2,a$t

%oad$ho& &3

Mgmt.. ) +ead

E$ta2li$h SP" 3

Side ,ar!

Syndication )

#llocation$

Dire!t

I0estmet

STAGE +(

Capital

Mar2ets

STAGE )(

Deal

De0elopmet

Lea$ 3

L%O%I%

STAGE

ONE

STAGE '(

Plai

the Trasa!tio

Match' (arget )

*eo+ocate

,ommitment

,ommittee

Deal

La/!h


8/31




Oral Mucositis

Gout


Bone Metastasis

Brain Cancer

Breast Cancer

Cervical Cancer


Enometrial Cancer

E!in" #arcoma

Gastric Cancer


Hea An Neck Cancer

Ho"kin Lymphoma

%iney Cancer

Liver Cancer



Melanoma

Multiple Myeloma

Non&Ho"kin Lymphoma


Ovarian Cancer

'ancreatic Cancer

$esticular Cancer

$hyroi Cancer





#epsis



An"ina 'ectoris

Atrial .ibrillation



Hypertension


Acute 'ain

An/iety Disorers

Chronic 'ain

Dementia

Diabetic Neuropathy


'arkinson0s Disease



#chi1ophrenia


Liver Cirrhosis

Chilhoo Enuresis


Hyperparathyroiism

Hyperthyroiism


Cytome"alovirus

.un"al ,n-ections


H2N2 ,n-ection

Herpes 3oster

H,+&2 ,n-ection













Hospital #upplies

#yrin"es an Neeles



,nhalation #ystems




Ophthalmic Devices




EN$ Devices

Hearin" ,mplants

Dia"nostic Devices







Bone Densitometry





Healthcare ,$




Orthopeic Devices



$rauma .i/ation



#pinal #ur"eryEnoscopy Devices 4 instruments



Genetic $estin"

Clinical Chemistry

Hematolo"y

,mmuno Chemistry



'atient Monitorin"




Neurolo"y Devices




Raiosur"ery

M

EDTE

CH

&

DIA

GNOSTIC

S

BIOPH

ARM

ACE

UTICALS

APPENDICES


9/31




Oral Mucositis

Gout


Bone Metastasis

Brain Cancer

Breast Cancer

Cervical Cancer


Enometrial Cancer

E!in" #arcoma

Gastric Cancer


Hea An Neck Cancer

Ho"kin Lymphoma

%iney Cancer

Liver Cancer



Melanoma

Multiple Myeloma

Non&Ho"kin Lymphoma


Ovarian Cancer

'ancreatic Cancer

$esticular Cancer

$hyroi Cancer





#epsis



An"ina 'ectoris

Atrial .ibrillation



Hypertension


Acute 'ain

An/iety Disorers

Chronic 'ain

Dementia

Diabetic Neuropathy


'arkinson0s Disease



#chi1ophrenia


Liver Cirrhosis

Chilhoo Enuresis


Hyperparathyroiism

Hyperthyroiism


Cytome"alovirus

.un"al ,n-ections


H2N2 ,n-ection

Herpes 3oster

H,+&2 ,n-ection













Hospital #upplies

#yrin"es an Neeles



,nhalation #ystems




Ophthalmic Devices




EN$ Devices

Hearin" ,mplants

Dia"nostic Devices







Bone Densitometry





Healthcare ,$




Orthopeic Devices



$rauma .i/ation






Genetic $estin"

Clinical Chemistry

Hematolo"y

,mmuno Chemistry



'atient Monitorin"




Neurolo"y Devices




Raiosur"ery

M

EDTE

CH

&

DIA

GNOSTIC

S

BIOPH

ARM

ACE

UTICALS

STAGE ONE(

Optimizing the

Development Pathway

BEFORE D!RI"# $ %F&ER

&he &ransaction


10/31


Stae ONE( Be#ore4 D/ri4 A#ter the Deal'ea"thios/hange ena("es Emerging Groth hea"thare ompanies to optimize their most

important #inaning an) strategi priorities throghot the entire in+estment horizon

Selection )Segmentation

#$$em2lingEcoSy$tem$

,ompany+i$ting$

Pre$entation$ )-3M

5-+ 3Maret Data

Management )/-D

Compa1

Pro#ile

Friend$ )

Follo&er$

,ommunitie$ )

*roup$

,linical )

Maret %e$earch(agging

Xchange

+ife+ine$!

Integrated Social

Media

E!oS1stem

Positioi

,u$tom ,ontent6e&$ Flo&

6otification$

Private 3 Pu2lic

"aluation$

Xchange +ive!

7o$ted ,hat

%ating$ )

%evie&$

Expert -pinion

1e2,a$t$Eaemet

(argeting )(racing

Me$$aging )#lert$

*rand %ound$!1e2,a$t

Shar (an! Xchange,onference$

Relatioship

89 million Data

Point$

';;; ,oncurrent

Experiment$

(rending )

#ctivity Score$

Mile$tone$ )

Inflection Point$

Sentiment )

Prediction

Meas/res &

S!ori

Di b ti N h th


11/31




Oral Mucositis

Gout


Bone Metastasis

Brain Cancer

Breast Cancer

Cervical Cancer


Enometrial Cancer

E!in" #arcoma

Gastric Cancer


Hea An Neck Cancer

Ho"kin Lymphoma

%iney Cancer

Liver Cancer



Melanoma

Multiple Myeloma

Non&Ho"kin Lymphoma


Ovarian Cancer

'ancreatic Cancer

$esticular Cancer

$hyroi Cancer





#epsis



An"ina 'ectoris

Atrial .ibrillation



Hypertension


Acute 'ain

An/iety Disorers

Chronic 'ain

Dementia

Diabetic Neuropathy


'arkinson0s Disease



#chi1ophrenia


Liver Cirrhosis

Chilhoo Enuresis


Hyperparathyroiism

Hyperthyroiism


Cytome"alovirus

.un"al ,n-ections


H2N2 ,n-ection

Herpes 3oster

H,+&2 ,n-ection













Hospital #upplies

#yrin"es an Neeles



,nhalation #ystems




Ophthalmic Devices




EN$ Devices

Hearin" ,mplants

Dia"nostic Devices







Bone Densitometry





Healthcare ,$




Orthopeic Devices



$rauma .i/ation






Genetic $estin"

Clinical Chemistry

Hematolo"y

,mmuno Chemistry



'atient Monitorin"




Neurolo"y Devices




Raiosur"ery

M

EDTE

CH

&

DIA

GNOSTIC

S

BIOPH

ARM

ACE

UTICALS

STAGE '(&ransaction Planning


12/31


Healthios6!hae Compa1 Pro#ileIN A 0ING2E $AR3ET EN4IRON$ENT, 'ea"thios/hange onnets 5,666 Emerging

Groth hea"thare ompanies in 789: ontries ith 86,666 in+estors in 7;6: asset "asses

an)


13/31


Do!/met De0elopmet'ea"thios transation proess has (een per#ete) e*"si+e"y #or the emerging groth hea"thare



STAGE '(

Plai

the Trasa!tio

Xchange Profile

DocumentDevelopment

Financial Model

to Pea! "alue

#lternative$

%evie&

Match' (arget )

*eo+ocate

,ommitment

,ommittee

Deal

La/!h

Executive Summary

-ffering Memorandum

Management Pre$entation

6on0,onfidential Data

Mareting Material

Product Demon$tration$

(e$timonial$


14/31


Fia!ial Pro8e!tio to 9Pea2: *al/e'ea"thios transation proess has (een per#ete) e*"si+e"y #or the emerging groth hea"thare



STAGE '(

Plai

the Trasa!tio

Xchange Profile

DocumentDevelopment

Financial Model

to Pea! "alue

#lternative$

%evie&

Match' (arget )

*eo+ocate

,ommitment

,ommittee

Deal

La/!h

*al/e

-perating! Document

Manu$cript for the /u$ine$$

%oadmap for Mile$tone$ ) Inflection Point$

?ard$tic for "aluation

6egotiating (ool

P/rpose

,ritical Mile$tone$"alue Inflection Point$

,linical3 %egulatory Path&ay$

Detailed co$t evaluation

(iming #$$umption$

Exit Path&ay$

Str/!t/re

"olume' "alue' #SP' Segment' *eography

Integrated /alance Sheet3 Income Statement3 ,a$h Flo&

-ffering Documentation

,omplete Source$ ) 4$e$ of ,a$h


15/31


Fia!i a$ Stratei! Alterati0es'ea"thios transation proess has (een per#ete) e*"si+e"y #or the emerging groth hea"thare



STAGE '(

Plai

the Trasa!tio

Xchange Profile

DocumentDevelopment

Financial Model

to Pea! "alue

#lternative$

%evie&

Match' (arget )

*eo+ocate

,ommitment

,ommittee

Deal

La/!h


16/31


Mat!hi4 Tareti & GeoLo!atio'ea"thios transation proess has (een per#ete) e*"si+e"y #or the emerging groth hea"thare



STAGE '(

Plai

the Trasa!tio

Xchange Profile

DocumentDevelopment

Financial Model

to Pea! "alue

#lternative$

%evie&

Match' (arget )

*eo+ocate

,ommitment

,ommittee

Deal

La/!h

Diabetic NephropathyC i l D i


17/31




Oral Mucositis

Gout


Bone Metastasis

Brain Cancer

Breast Cancer

Cervical Cancer


Enometrial Cancer

E!in" #arcoma

Gastric Cancer


Hea An Neck Cancer

Ho"kin Lymphoma%iney Cancer

Liver Cancer



Melanoma

Multiple Myeloma

Non&Ho"kin Lymphoma


Ovarian Cancer

'ancreatic Cancer

$esticular Cancer

$hyroi Cancer





#epsis



An"ina 'ectoris

Atrial .ibrillation



Hypertension


Acute 'ain

An/iety Disorers

Chronic 'ain

Dementia

Diabetic Neuropathy


'arkinson0s Disease



#chi1ophrenia


Liver Cirrhosis

Chilhoo Enuresis


Hyperparathyroiism

Hyperthyroiism


Cytome"alovirus

.un"al ,n-ections


H2N2 ,n-ection

Herpes 3osterH,+&2 ,n-ection













Hospital #upplies

#yrin"es an Neeles



,nhalation #ystems




Ophthalmic Devices




EN$ Devices

Hearin" ,mplants

Dia"nostic Devices






Nuclear ,ma"in" E6uipment

Contrast Meia ,n(ectors

Bone Densitometry





Healthcare ,$




Orthopeic Devices



$rauma .i/ation






Genetic $estin"

Clinical Chemistry

Hematolo"y

,mmuno Chemistry



'atient Monitorin"




Neurolo"y Devices




Raiosur"ery

M

EDTE

CH

&

DIA

GNOSTIC

S

BIOPHARM

ACE

UTICALS

STAGE )(Deal Development


18/31


Eaemet'ea"thios transation proess has (een per#ete) e*"si+e"y #or the emerging groth hea"thare



Engagement

Po$itioning ),ommunication

Solicitation )

Follo& 4p

Management

Meeting$

Data %oom

(rending Data'

#ctivity' Scoring

Lea$ 3

L%O%I%

STAGE )(

Co#irmi

Iterest


19/31


Positioi & Comm/i!atios'ea"thios transation proess has (een per#ete) e*"si+e"y #or the emerging groth hea"thare



Engagement


Solicitation )

Follo& 4p

Management

Meeting$

Data %oom

(rending Data'

#ctivity' Scoring

Lea$ 3

L%O%I%

STAGE )(

Co#irmi

Iterest


20/31


Deal De0elopmet Pro!ess'ea"thios transation proess has (een per#ete) e*"si+e"y #or the emerging groth hea"thare



; to @; call$ per &ee

Managing Divergent Financial ) Strategic %ationale

Developing 9Co8oit Coses/s: to mea$ure tran$action

momentum

Identifying ,hampion$

,oordinating (arget Deal (eam

E$ta2li$hing Due Diligence Prioritie$

,onfirming Proce$$

Setting Expectation$

/uilding Mea$urement ) %eport Sy$tem$.

Managing #ccounta2ilitie$

Engagement


Solicitation )

Follo& 4p

Management

Meeting$

Data %oom

(rending Data'

#ctivity' Scoring

Lea$ 3

L%O%I%

STAGE )(

Co#irmi

Iterest


21/31





Presenters' (EO) Presi*ent) (FO

Esta("ish Cre)i(i"ity

Re#"et The 4ision

Un)erstan) The $ar%et

Be Organize) 3no The Fats

Disp"ay 'igh Tehnia" !ro#iieny

0ho Detai"e) Finania" !"an

Un)erstan) Operationa" Comp"e*ities

0et Rea"isti E*petations

+ell &he ,+izzle-'

Uni-e 4a"e !roposition

Tay"or To The !artner, In+estor, Byer

Ot"ine 0ynergies An) 0trategi Fit

Arti"ate 2ong1term 0trategi !"an

Engagement


Solicitation )

Follo& 4p

Management

Meeting$

Data %oom

(rending Data'

#ctivity' Scoring

Lea$ 3

L%O%I%

STAGE )(

Co#irmi

Iterest


22/31





-rganiation' Management ' Employee$

,u$tomer$' Sale$' Mareting

-peration$

Manufacturing

Financial %eport$

I3P' +egal

/oard and *overnance Matter$

Environmental

+ensitive Inormation /ay Be +tage*

Everything (omes O0t Beore (heck Is +igne*

Engagement


Solicitation )

Follo& 4p

Management

Meeting$

Data %oom

(rending Data'

#ctivity' Scoring

Lea$ 3

L%O%I%

STAGE )(

Co#irmi

Iterest


23/31





$erger an)

a-isition pre)ition.

Note that on#i)ene

is a (it sma""er than ;.

The ata"

nm(er o# months

(e#ore the ne*t

transation is =.

>e pre)ite) 8.

The ata" nm(er

o# months (e#ore

the ne*t transation

is ;;. >e pre)ite)

;6.

The ata" +a"e o# the

ne*t transation is ?;@6

mi""ion an) e pre)ite)

?;@6 mi""ion.

The ata" +a"e o#

the ne*t transation

is ?hen is it going to happen

'o (ig i"" it (e

Engagement


Solicitation )

Follo& 4p

Management

Meeting$

Data %oom

(rending Data'

#ctivity' Scoring

Lea$ 3

L%O%I%

STAGE )(

Co#irmi

Iterest

t


24/31





Strategic rationale for purcha$e

Indicative price range and form of con$ideration

Propo$ed deal $tructure

De$cription of financing' including $ource$ and initial term$

(ran$action approval proce$$ for the acAuiring organiation

De$cription of due diligence reAuirement$ and timing

Engagement


Solicitation )

Follo& 4p

Management

Meeting$

Data %oom

(rending Data'

#ctivity' Scoring

Lea$ 3

L%O%I%

STAGE )(

Co#irmi

Iterest


Diabetic RetinopathyCariovascular Devices


25/31



Oral Mucositis

Gout


Bone Metastasis

Brain Cancer

Breast Cancer

Cervical Cancer


Enometrial Cancer

E!in" #arcoma

Gastric Cancer


Hea An Neck Cancer


Liver Cancer



Melanoma

Multiple Myeloma

Non&Ho"kin Lymphoma


Ovarian Cancer

'ancreatic Cancer

$esticular Cancer

$hyroi Cancer





#epsis



An"ina 'ectoris

Atrial .ibrillation



Hypertension


Acute 'ain

An/iety Disorers

Chronic 'ain

Dementia

Diabetic Neuropathy

Obsessive&Compulsive Disorer

Osteoarthritis 'ain

'arkinson0s Disease



#chi1ophrenia


Liver Cirrhosis

Chilhoo Enuresis


Hyperparathyroiism

Hyperthyroiism


Cytome"alovirus

.un"al ,n-ections


H2N2 ,n-ection













Hospital #upplies

#yrin"es an Neeles



,nhalation #ystems




Ophthalmic Devices




EN$ Devices

Hearin" ,mplants

Dia"nostic Devices







Contrast Meia ,n(ectorsBone Densitometry





Healthcare ,$




Orthopeic Devices



$rauma .i/ation






Genetic $estin"

Clinical Chemistry

Hematolo"y

,mmuno Chemistry



'atient Monitorin"




Neurolo"y Devices




Raiosur"ery

M

EDTE

CH

&

DIA

GNOSTIC

S

BIOPHARM

ACE

UTICALS

STAGE +((apital /arkets


26/31





,onfirming the

%ule Set!.

(each0In &ithDirect Inve$tor$

Management

1e2,a$t

%oad$ho& &3

Mgmt.. ) +ead

E$ta2li$h SP" 3

Side ,ar!

Syndication )

#llocation$

Dire!t

I0estmet

STAGE +(

Capital

Mar2ets

Limite$ Parters4 Famil1 O##i!e4 E$o;mets4

Forei Tr/sts4 Pri0ate Ba2s4 So0erei

Port#olio

Compa1

='

1. I"+&I&!&IO"%2

2E%DER+HIP

3. +&R%&E#I(

4%2ID%&IO"

5. E+&%B2I+HED,E6I&-

P%&H7%8

*et/re

Capital

Pri0ate

E?/it1

Gro;th

E?/it1

He$e

F/$s


27/31





,onfirming the

%ule Set!.

(each0In &ithDirect Inve$tor$

Management

1e2,a$t

%oad$ho& &3

Mgmt.. ) +ead

E$ta2li$h SP" 3

Side ,ar!

Syndication )

#llocation$

Dire!t

I0estmet

STAGE +(

Capital

Mar2ets

Limite$ Parters4 Famil1 O##i!e4 E$o;mets4

Forei Tr/sts4 Pri0ate Ba2s4 So0erei

Port#olio

Compa1

='

"O FEE9 "O

(%RR8

+HOR&E"ED

HO2D PERIOD+

#RE%&ER

2I:!IDI&8

*et/re

Capital

Pri0ate

E?/it1

Gro;th

E?/it1

He$e

F/$s


Diabetic RetinopathyCariovascular Devices

' th ti H t + l


28/31



Oral Mucositis

Gout


Bone Metastasis

Brain Cancer

Breast Cancer

Cervical Cancer


Enometrial Cancer

E!in" #arcoma

Gastric Cancer


Hea An Neck Cancer


Liver Cancer



Melanoma

Multiple Myeloma

Non&Ho"kin Lymphoma


Ovarian Cancer

'ancreatic Cancer

$esticular Cancer

$hyroi Cancer





#epsis



An"ina 'ectoris

Atrial .ibrillation



Hypertension


Acute 'ain

An/iety Disorers

Chronic 'ain

Dementia

Diabetic Neuropathy

Obsessive&Compulsive Disorer

Osteoarthritis 'ain

'arkinson0s Disease



#chi1ophrenia


Liver Cirrhosis

Chilhoo Enuresis


Hyperparathyroiism

Hyperthyroiism


Cytome"alovirus

.un"al ,n-ections


H2N2 ,n-ection













Hospital #upplies

#yrin"es an Neeles



,nhalation #ystems




Ophthalmic Devices




EN$ Devices

Hearin" ,mplants

Dia"nostic Devices







Contrast Meia ,n(ectorsBone Densitometry





Healthcare ,$




Orthopeic Devices



$rauma .i/ation






Genetic $estin"

Clinical Chemistry

Hematolo"y

,mmuno Chemistry



'atient Monitorin"




Neurolo"y Devices


,nterventional Neurolo"y

C#. Mana"ement


Raiosur"ery

M

EDTE

CH

&

DIA

GNOSTIC

S

BIOPHARM

ACE

UTICALS

STAGE ,(D0e Diligence


29/31





,ommercial'

Strategy D.D.

(echnicalEvaluation

Financial Model

-rganiational

Matter$

Financing

,on$ideration$

-perating Plan

De#iiti0e

Areemet

STAGE ,(

D/e

Dilie!eSuperior' ,omprehen$ive ,ompany Po$itioning

Data0Driven (argeting ) Matching

SeAuencing Due Diligence

,horeographing #cce$$ to Management

Monitoring ) Mea$uring Data %oom #ctivity

(a$ing! Deal (eam Participant$

(racing Procedure and Proce$$ v$. Expectation$

,ontinuou$ ,ommunication

%e$olving (hre$hold! I$$ue$

#nticipating Deal Strategy

Planning %e$pon$e$ ) Executing on Progre$$

,ontemplating #lternative$


30/31

N i i & Cl


31/31


PRICE @ CASH PROCEEDS NO T

7__Strategic Partnering Financing Process (2).pptx

Documents